Medtronic Insulin Pumps
On November 21, 2019, Medtronic, Inc. initiated a recall of two models of insulin pumps intended to be used by individuals with Type 1 diabetes. The recall includes over 300,000 individual pumps. The FDA identified the recall as a “Class I recall, the most serious type of recall” because the use of “these devices may cause serious injuries or death.” Medtronic has stated the pumps have already been involved in 26,421 complaints, which includes 2,175 injuries and one death.
Medtronic has recalled the Minimed 630G and Minimed 670G because these pumps have a missing or broken “retainer ring.” This retainer ring helps to lock the insulin cartridge into place in the pumps reservoir compartment. Medtronic has stated that if the cartridge is not locked firmly into place, the device may deliver the wrong amount of insulin to the user.
Minnesota-based Medtronic, Inc. is one of the world’s largest medical device corporations as well as the largest manufacturers of insulin pumps and infusion sets in the world. If pump’s retainer ring is broken or missing, and the device delivers too much or too little insulin to the user, serious, life-threatening consequences may occur. The FDA has identified the following possible injuries:
- Hypoglycemia – low blood glucose
- Hyperglycemia – high blood glucose
- Loss of consciousness
- Nausea and vomiting
- Shortness of breath
Any person age 16 or older with Type 1 diabetes that uses a Model 630G distributed between September 2016 to October 2019, or a Model 670G distributed between June 2017 to August 2019, may be at risk.
If you or a loved one has been injured by a recalled Medtronic insulin pump, contact Fears Nachawati Law Firm. Our attorneys have the experience and resources to hold the world’s largest corporations accountable for producing defective products.